Skip to main content
. 2019 Jun 13;12(9):1147–1154. doi: 10.1016/j.tranon.2019.03.006

Table 2.

Demographic and clinicopathologic characteristics of 50 PDACs with or without T2DM in validation cohort

Parameters PDAC without T2DM PDAC with T2DM P value
Age (years, median) 60 (39–74) 70.5 (46–83) 0.077
Gender (Female/male) 11/21 9/9 0.370
Stage (I + II/III + IV) 27/5 16/2 1.000